Biotechnology Law Report

The domain of human stem cell inventions is a complex area muddled with ethical and moral dilemmas and the almost miraculous potential of human stem cell-based inventions in curing diseases such as diabetes, heart diseases, leukemia, and lymphoma. While the ethical and moral concerns in this area need to be dealt with proper sensitivity, the billion-dollar stem cell market that can cure so many common but lethal diseases also needs to have proper patent protection. The article aims to portray the challenges of the patenting landscape of inventions related to human stem cells across the USA, Europe, and India from the patent application requirement angle: how much India is lagging and how India can ensure that it does not fall far behind. The study reveals that compared to the USA, Europe, and the world, a smaller number of patent applications are being filed in this area in India. The top technology companies working on human stem cells rarely come to India, and India is giving little to no protection to inventions related to human stem cell technology due to subject-matter restrictions. Europe has balanced the ethical and moral issues with the need for patentability protection of this crucial technology. This article will show how India needs to take a more balanced approach in this regard.

Genetically modified (GM) crops are developed and marketed when there is some professed advantage to either the producer or consumer of these foods. Uncertainty about the impact of GM crops is one rationale for the widespread public mistrust of this technology. The issues, whether legal or environmental, relating to GM crops or foods have sparked intense debate in various parts of the world, including India. It is imperative to ascertain the judicious and equitable utilization of GM crops in pursuit of the objectives to alleviate hunger and attain food security. This technology has raised enormous expectations, leading to heated political controversies and an ongoing debate about how to evaluate these technologies. This study seeks to conduct an analysis of the issues associated with GM crop safety, with an emphasis on how national regimes are keeping pace with international regulatory initiatives. This study highlights the lack of inclusive laws as well as efficient enforcement for biosafety issues. The model expresses the necessity of safeguarding human health and the environment from the probable hostile effects of the products of present biotechnology.